- NCIt
- C8101
Loading cancer entity…
Loading cancer entity…
Clinical trials
1,164 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06462716 | A Phase l Study of By101298, an Oral DNA-PK Inhibitor, in Patients With Advanced Solid Tumors | unknown | Phase 1 | 36 | Chengdu Baiyu Pharmaceutical Co., Ltd.INDUSTRY | 1 | Apr 13, 2025 | clinicaltrials |
| NCT06473948 | To Assess the Effects of Single Dose of JMKX001899 on QTc Interval in Healthy Subjects | unknown | Phase 1 | 27 | JemincareINDUSTRY | 0 | Jun 25, 2024 | clinicaltrials |
| NCT06469268 |
| Development and Application Study of ePRO Software for Managing Cancer Patients Throughout the Treatment Period |
| unknown |
| N/A |
| 100 |
| Shikai WuOTHER |
| 1 |
| Jun 21, 2024 |
| clinicaltrials |
| NCT06136065 | 68 Gallium-Fibroblast Activating Protein Inhibitors-46 Positron Emission Tomography - Computerized Tomography for Molecular Assessment of Fibroblast Activation and Risk Assessment in Solid Tumors(FAPI) | unknown | Phase 2 | 100 | Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCSOTHER | 1 | Jun 4, 2024 | clinicaltrials |
| NCT06433726 | A Phase l Study of By101921, an Oral PARP7 Inhibitor, in Patients With Advanced Solid Tumors | unknown | Phase 1 | 60 | Chengdu Baiyu Pharmaceutical Co., Ltd.INDUSTRY | 1 | May 30, 2024 | clinicaltrials |
| NCT05605197 | U87 CART in Treatment of Advanced Solid Tumor | unknown | Phase 1 | 12 | Shanghai Unicar-Therapy Bio-medicine Technology Co.,LtdINDUSTRY | 1 | May 28, 2024 | clinicaltrials |
| NCT04092673 | Study of eFT226 in Subjects With Selected Advanced Solid Tumor Malignancies(Zotatifin) | unknown | Phase 1 / Phase 2 | 30 | Effector TherapeuticsINDUSTRY | 1 | May 21, 2024 | clinicaltrials |
| NCT03004755 | The PEACE (Posthumous Evaluation of Advanced Cancer Environment) Study(PEACE) | unknown | — | 500 | University College, LondonOTHER | 1 | May 10, 2024 | clinicaltrials |
| NCT06348290 | Study to Evaluate the Drug-drug Interaction of JMKX001899 in Healthy Subjects | unknown | Phase 1 | 72 | JemincareINDUSTRY | 0 | Apr 4, 2024 | clinicaltrials |
| NCT06075849 | Phase I Study to Evaluate Safety and Anti-tumor Activity of PB101, an Anti-angiogenic Immunomodulating Agent | unknown | Phase 1 | 30 | Panolos BioscienceINDUSTRY | 1 | Feb 23, 2024 | clinicaltrials |
| NCT06240767 | Clinical Study on the Treatment of Advanced Recurrent Tumors With Anticancer Mouse Characteristic Human Neutrophils | unknown | Phase 1 | 18 | Wuxi People's HospitalOTHER | 1 | Feb 5, 2024 | clinicaltrials |
| NCT06232863 | A Study of BH009 in Head and Neck Squamous Cell Carcinoma and Ovarian Cancer | unknown | Phase 1 | 24 | Zhuhai Beihai Biotech Co., LtdINDUSTRY | 1 | Feb 2, 2024 | clinicaltrials |
| NCT04983810 | A Study to Investigate Fadraciclib (CYC065), in Subjects With Advanced Solid Tumors and Lymphoma | unknown | Phase 1 / Phase 2 | 330 | Cyclacel Pharmaceuticals, Inc.INDUSTRY | 3 | Jan 25, 2024 | clinicaltrials |
| NCT05388487 | Tolerability and Safety of HF1K16 Injection in Patients With Refractory Solid Tumors | unknown | Phase 1 | 54 | HighField Biopharmaceuticals CorporationINDUSTRY | 1 | Jan 16, 2024 | clinicaltrials |
| NCT04739293 | Study of ON 123300 in Patients With Advanced Cancer | unknown | Phase 1 | 36 | Traws Pharma, Inc.INDUSTRY | 1 | Dec 7, 2023 | clinicaltrials |
| NCT06056323 | A Study of HB0045 Injection in Patients With Advanced Solid Tumors | unknown | Phase 1 / Phase 2 | 71 | Shanghai Huaota Biopharmaceutical Co., Ltd.INDUSTRY | 1 | Oct 23, 2023 | clinicaltrials |
| NCT03382340 | IMX-110 in Patients With Advanced Solid Tumors | unknown | Phase 1 / Phase 2 | 70 | Immix Biopharma Australia Pty LtdINDUSTRY | 2 | Sep 28, 2023 | clinicaltrials |
| NCT06027346 | A Study of Bio-008 in Subjects With Advanced or Metastatic Solid Tumours | unknown | Phase 1 | 60 | Shijiazhuang Yiling Pharmaceutical Co. LtdINDUSTRY | 1 | Sep 7, 2023 | clinicaltrials |
| NCT05296772 | Phase 1 First-in-human Study of JS014 | unknown | Phase 1 | 60 | Anwita BiosciencesINDUSTRY | 1 | Sep 6, 2023 | clinicaltrials |
| NCT05986981 | MUC1 Therapeutic Tumor Vaccine in Advanced Solid Cancers | unknown | Phase 2 | 20 | Peking Union Medical College HospitalOTHER | 1 | Aug 14, 2023 | clinicaltrials |
| NCT05747339 | A Clinical Study on the Efficacy and Mechanism of Tumor Treatment Vaccine (TTV) for Recurrent and Refractory Advanced Solid Tumors | unknown | N/A | 50 | Wuxi People's HospitalOTHER | 0 | Jun 13, 2023 | clinicaltrials |
| NCT04053673 | Phase 1 Study of RBN-2397, an Oral PARP7 Inhibitor, in Patients With Solid Tumors | unknown | Phase 1 | 130 | Ribon Therapeutics, Inc.INDUSTRY | 2 | Mar 28, 2023 | clinicaltrials |
| NCT05759234 | A Study of HS248 in Patients With Advanced Solid Tumors | unknown | Phase 1 | 24 | Hanhui Pharmaceutical Co., LtdINDUSTRY | 1 | Mar 8, 2023 | clinicaltrials |
| NCT03475953 | A Phase I/II Study of Regorafenib Plus Avelumab in Solid Tumors(REGOMUNE) | unknown | Phase 1 / Phase 2 | 747 | Institut BergoniéOTHER | 1 | Mar 3, 2023 | clinicaltrials |
| NCT05538676 | Fluoride-labeled Boronophenylalanine PET Imaging in Patients With Solid Tumors | unknown | — | 10 | Xiaohua ZhuOTHER | 1 | Feb 13, 2023 | clinicaltrials |
| NCT05666635 | Study of LTC004 in Subjects With Advanced Malignant Tumors | unknown | Phase 1 | 368 | LetolabINDUSTRY | 0 | Dec 28, 2022 | clinicaltrials |
| NCT05416710 | Universal Germline Testing in the Community(UNITY) | unknown | — | 1,000 | Invitae CorporationINDUSTRY | 1 | Dec 7, 2022 | clinicaltrials |
| NCT05623891 | Safety Study of 177Lu-Anti-ED-B mAbs SPECT Imaging in Patients With ED-B Positive Solid Tumors | unknown | Early Phase 1 | 10 | Affiliated Hospital of Jiangnan UniversityOTHER | 1 | Nov 23, 2022 | clinicaltrials |
| NCT04976218 | TGFβR-KO CAR-EGFR T Cells in Previously Treated Advanced EGFR-positive Solid Tumors | unknown | Phase 1 | 30 | Chinese PLA General HospitalOTHER | 1 | Nov 16, 2022 | clinicaltrials |
| NCT05442996 | A Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Characteristics, and Preliminary Efficacy of HLX35 in Combination With HLX10 in Patients With Advanced or Metastatic Solid Tumors | unknown | Phase 1 | 30 | Shanghai Henlius BiotechINDUSTRY | 0 | Jul 5, 2022 | clinicaltrials |
| NCT05322720 | HR Positive, HER2 Negative Advanced Breast Cancer With Progression After Endocrine Therapy | unknown | Phase 2 | 50 | Taizhou EOC Pharma Co., Ltd.INDUSTRY | 0 | Apr 12, 2022 | clinicaltrials |
| NCT05252975 | Improving Cyberknife Spinal Stereotactic Radiotherapy in Difficult to Treat Cases (IMPRESS)(IMPRESS) | unknown | N/A | 10 | Royal Marsden NHS Foundation TrustOTHER | 1 | Feb 23, 2022 | clinicaltrials |
| NCT04671654 | Systematic Evaluation of Human Explant Model Systems Engineering(SEEDLING) | unknown | — | 100 | University Hospital HeidelbergOTHER | 1 | Dec 21, 2021 | clinicaltrials |
| NCT05060263 | A Study of of HOT1030 in Patients With Advanced Solid Tumors | unknown | Phase 1 | 42 | Huabo Biopharm Co., Ltd.INDUSTRY | 1 | Sep 29, 2021 | clinicaltrials |
| NCT04859777 | A Study of MPT-0118 in Subjects With Advanced or Metastatic Refractory Solid Tumors | unknown | Phase 1 | 70 | Monopteros Therapeutics Inc.INDUSTRY | 1 | Sep 16, 2021 | clinicaltrials |
| NCT04989010 | Safety Study of 89Zr-Anti-CLDN18.2 mAbs PET Imaging in Patients With CLDN18.2 Positive Solid Tumors | unknown | N/A | 20 | Wuxi No. 4 People's HospitalOTHER | 1 | Aug 4, 2021 | clinicaltrials |
| NCT04971369 | Safety Study of 89Zr-NY001 PET Imaging in Patients | unknown | N/A | 20 | Wuxi No. 4 People's HospitalOTHER | 1 | Jul 27, 2021 | clinicaltrials |
| NCT04977128 | 89Zr-labeled KN035 PET Imaging in Patients With PD-L1 Positive Solid Tumors | unknown | N/A | 20 | Wuxi No. 4 People's HospitalOTHER | 1 | Jul 26, 2021 | clinicaltrials |
| NCT04556669 | Anti-PD-L1 Armored Anti-CD22 CAR-T/CAR-TILs Targeting Patients With Solid Tumors | unknown | Phase 1 | 30 | Hebei Senlang Biotechnology Inc., Ltd.INDUSTRY | 1 | May 27, 2021 | clinicaltrials |
| NCT04175899 | Effectiveness of Pharmacist Intervention on Capecitabine Relative Dose Intensity, Adherence, Knowledge & Safety Among Cancer Patients in Malaysia(POCCP1) | unknown | N/A | 106 | Ministry of Health, MalaysiaOTHER_GOV | 1 | Mar 8, 2021 | clinicaltrials |
| NCT03545815 | Study of CRISPR-Cas9 Mediated PD-1 and TCR Gene-knocked Out Mesothelin-directed CAR-T Cells in Patients With Mesothelin Positive Multiple Solid Tumors. | unknown | Phase 1 | 10 | Chinese PLA General HospitalOTHER | 1 | Aug 10, 2020 | clinicaltrials |
| NCT04169178 | Evaluate Safety, Tolerability and PK of HLX55 in Patients With Advanced Solid Tumors With Different cMET Status | unknown | Phase 1 | 98 | Henlix, IncINDUSTRY | 1 | May 1, 2020 | clinicaltrials |
| NCT03160833 | A Study of HMPL-453 in Patients With Advanced Solid Malignancies | unknown | Phase 1 / Phase 2 | 33 | Hutchison Medipharma LimitedINDUSTRY | 1 | Feb 13, 2020 | clinicaltrials |
| NCT03324841 | POA Prospective Repository | unknown | — | 10,000 | Caris Science, Inc.INDUSTRY | 1 | Jan 27, 2020 | clinicaltrials |
| NCT03927599 | Advanced Refractory Solid Tumors With TP53 Mutations Register Study | unknown | — | 100 | Tianjin Medical University Second HospitalOTHER | 1 | Aug 20, 2019 | clinicaltrials |
| NCT03977766 | Feasibility of a Process of Digital Validation of Chemotherapies in a Day Treatment Unit(CPV2-0) | unknown | N/A | 150 | Institut Paoli-CalmettesOTHER | 0 | Jun 6, 2019 | clinicaltrials |
| NCT01032278 | Effectiveness of Using Biomarkers to Detect and Identify Cardiotoxicity and Describe Treatment (PREDICT) | unknown | N/A | 597 | M.D. Anderson Cancer CenterOTHER | 1 | May 21, 2019 | clinicaltrials |
| NCT03929653 | Personalized Therapy of Molecular Tumor Board Participation With the Guidance of Next Generation Sequencing | unknown | — | 500 | Tianjin Medical University Second HospitalOTHER | 1 | Apr 29, 2019 | clinicaltrials |
| NCT00020605 | Naloxone in Treating Constipation in Patients Who Are Receiving Opioids for Chronic Pain | unknown | Phase 3 | — | Dana-Farber Cancer InstituteOTHER | 1 | Dec 13, 2018 | clinicaltrials |
| NCT03638804 | 89Zr-KN035 PET Imaging in Patients With Advanced Solid Tumors | unknown | N/A | 10 | The First Affiliated Hospital of Soochow UniversityOTHER | 1 | Dec 5, 2018 | clinicaltrials |
Data updated 22 days agoSource updated Apr 13, 2025source: clinicaltrials